Lee, W., Carey, L. M., Li, L., Xu, Z., Lai, Y. Y., Courtney, M. J., & Hohmann, A. G. (2018). ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability. Mol Pain.

Lee, Wan-Hung, Lawrence M. Carey, Li-Li Li, Zhili Xu, Yvonne Y. Lai, Michael J. Courtney, and Andrea G. Hohmann. "ZLc002, a Putative Small-molecule Inhibitor of NNOS Interaction With NOS1AP, Suppresses Inflammatory Nociception and Chemotherapy-induced Neuropathic Pain and Synergizes With Paclitaxel to Reduce Tumor Cell Viability." Mol Pain 2018.

Lee, Wan-Hung, et al. "ZLc002, a Putative Small-molecule Inhibitor of NNOS Interaction With NOS1AP, Suppresses Inflammatory Nociception and Chemotherapy-induced Neuropathic Pain and Synergizes With Paclitaxel to Reduce Tumor Cell Viability." Mol Pain 2018.